MXPA03011306A - Metodos para la preparacion y uso de 1a,24 (s) - hidroxivitamina d2. - Google Patents

Metodos para la preparacion y uso de 1a,24 (s) - hidroxivitamina d2.

Info

Publication number
MXPA03011306A
MXPA03011306A MXPA03011306A MXPA03011306A MXPA03011306A MX PA03011306 A MXPA03011306 A MX PA03011306A MX PA03011306 A MXPA03011306 A MX PA03011306A MX PA03011306 A MXPA03011306 A MX PA03011306A MX PA03011306 A MXPA03011306 A MX PA03011306A
Authority
MX
Mexico
Prior art keywords
dihydroxyvitamin
1alpha
preparation
methods
alpha
Prior art date
Application number
MXPA03011306A
Other languages
English (en)
Spanish (es)
Inventor
C Knutson Joyce
Original Assignee
Bone Care Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bone Care Int Inc filed Critical Bone Care Int Inc
Publication of MXPA03011306A publication Critical patent/MXPA03011306A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA03011306A 2001-06-26 2002-06-26 Metodos para la preparacion y uso de 1a,24 (s) - hidroxivitamina d2. MXPA03011306A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/891,963 US6538037B2 (en) 1991-01-08 2001-06-26 Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
PCT/US2002/020317 WO2003002110A1 (en) 2001-06-26 2002-06-26 METHODS FOR PREPARATION AND USE OF 1α,24(S)-DIHYDROXYVITAMIN D¿2?

Publications (1)

Publication Number Publication Date
MXPA03011306A true MXPA03011306A (es) 2004-03-19

Family

ID=25399131

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03011306A MXPA03011306A (es) 2001-06-26 2002-06-26 Metodos para la preparacion y uso de 1a,24 (s) - hidroxivitamina d2.

Country Status (10)

Country Link
US (1) US6538037B2 (enExample)
EP (1) EP1408939A4 (enExample)
JP (1) JP2004535441A (enExample)
KR (1) KR20040011559A (enExample)
CN (1) CN1520288A (enExample)
AU (1) AU2002315463B2 (enExample)
CA (1) CA2451039A1 (enExample)
IL (1) IL159067A0 (enExample)
MX (1) MXPA03011306A (enExample)
WO (1) WO2003002110A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) * 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6503893B2 (en) * 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
WO1999049870A1 (en) * 1998-03-27 1999-10-07 Oregon Health Sciences University Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
EA008072B1 (ru) * 2001-12-03 2007-02-27 Новацея, Инк. Фармацевтические составы, содержащие соединения активного витамина d
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20040058895A1 (en) * 2002-09-18 2004-03-25 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US20050026877A1 (en) * 2002-12-03 2005-02-03 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US20050020546A1 (en) * 2003-06-11 2005-01-27 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
WO2005097128A1 (en) * 2004-03-30 2005-10-20 Novacea, Inc. 1,4-bis-n-oxide azaanthracenediones and the use thereof
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20080293647A1 (en) * 2004-11-12 2008-11-27 Luciano Adorini Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
US20100009949A1 (en) * 2006-03-24 2010-01-14 Bioxell S.P.A. Novel method
CN109627279A (zh) * 2019-02-01 2019-04-16 浙江花园营养科技有限公司 一种活性维生素d3中间体的制备方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670190A (en) 1973-01-10 1987-06-02 Hesse Robert H 1-α-hydroxy vitamin D compounds and process for preparing same
US3880894A (en) 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
US4022891A (en) 1974-06-18 1977-05-10 Teijin Limited Novel 1α,24-dihydroxycholecalciferol compositions, novel precursors thereof, and processes for preparing them
GB1583749A (en) 1976-06-03 1981-02-04 Res Inst Medicine Chem Vitamin d derivatives
US4195027A (en) 1978-01-16 1980-03-25 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
JPS57149224A (en) 1981-03-13 1982-09-14 Chugai Pharmaceut Co Ltd Tumor-suppressing agent
US4338250A (en) 1981-04-27 1982-07-06 Wisconsin Alumni Research Foundation 1-Hydroxylation process
US4719204A (en) 1984-03-05 1988-01-12 Wisconsin Alumni Research Foundation Fowl bone mineralization with 28-NOR 1α-hydroxyvitamin D2 analogs
US4554106A (en) 1984-11-01 1985-11-19 Wisconsin Alumni Research Foundation Method for preparing 1α-hydroxyvitamin D compounds
IL78342A (en) 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
US5104864A (en) 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
US5098899A (en) 1989-03-06 1992-03-24 Trustees Of Boston University Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites
US4973584A (en) 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives
US5260290A (en) 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
AU650286B2 (en) 1990-09-21 1994-06-16 Bone Care International, Inc. Novel 1alpha-hydroxy vitamin D4 and novel intermediates and analogues
US5798345A (en) 1990-09-21 1998-08-25 Bone Care International, Inc. Method of inhibiting the hyperproliferation of malignant cells
US5763428A (en) 1990-09-21 1998-06-09 Bone Care International, Inc. Methods of treating skin disorders with novel 1a-hydroxy vitamin D4 compounds and derivatives thereof
US5801164A (en) 1990-09-21 1998-09-01 Bone Care International, Inc. Methods of treating osteoporosis prophylactically or therapeutically
US6025346A (en) 1990-09-21 2000-02-15 Bone Care International, Inc. 1α-hydroxy vitamin D4 and novel intermediates and analogues
DE69229103T2 (de) 1991-01-08 1999-10-14 Bone Care International Inc. Verfahren zur herstellung und verwendung von 1alpha,24-dihydroxy vitamin-d2
US5786348A (en) 1991-01-08 1998-07-28 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2
US6166000A (en) 1991-01-08 2000-12-26 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-Dihydroxy vitamin . D.sub2
AU650751B2 (en) 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
ATE181062T1 (de) 1992-08-28 1999-06-15 Bone Care Int Inc 1alpha,24(s)-dihydroxy vitamin d2, seine synthese und verwendung
US5763429A (en) 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
FR2738745B1 (fr) * 1995-09-15 1997-10-24 Cird Galderma Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide, et leurs utilisations
DE19549243A1 (de) 1995-12-21 1997-06-26 Schering Ag Pharmazeutische Präparate enthaltend Clathrate von Cyclodextrinen und nichtnatürliche Vitamin D-Analoga
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
AUPO727097A0 (en) 1997-06-10 1997-07-03 Unisearch Limited Method of treatment of hepatoma and pharmaceutical compositions for use therein
US6087350A (en) 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
WO1999049027A1 (en) 1998-03-25 1999-09-30 Cutanogen, Inc. Methods for prevention and treatment of cancer
WO1999049870A1 (en) 1998-03-27 1999-10-07 Oregon Health Sciences University Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
US20010002396A1 (en) 1998-07-16 2001-05-31 Charles Achkar Compositions and methods of treating skin conditions
DK1220676T3 (da) 1999-09-29 2005-09-05 Colotech As Forebyggelse af colorektal cancer
ES2300323T3 (es) 2000-03-02 2008-06-16 Univ Pittsburgh Quimioterapia combinada.

Also Published As

Publication number Publication date
CN1520288A (zh) 2004-08-11
AU2002315463B2 (en) 2007-05-31
KR20040011559A (ko) 2004-02-05
WO2003002110A1 (en) 2003-01-09
IL159067A0 (en) 2004-05-12
EP1408939A4 (en) 2007-01-24
US6538037B2 (en) 2003-03-25
JP2004535441A (ja) 2004-11-25
US20020032179A1 (en) 2002-03-14
CA2451039A1 (en) 2003-01-09
EP1408939A1 (en) 2004-04-21

Similar Documents

Publication Publication Date Title
MXPA03011306A (es) Metodos para la preparacion y uso de 1a,24 (s) - hidroxivitamina d2.
IL144559A0 (en) Antibodies for cancer therapy and diagnosis
IL147803A0 (en) 28-epirapalogs
CA2186260A1 (en) Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide
AU6853598A (en) Aligner, exposure method using the aligner, and method of manufacture of circuitdevice
HUP0002476A3 (en) Amine compounds, their production and use
ZA991489B (en) Oxaliplatin solution formulations and the method of use thereof.
IL143674A0 (en) Metalloproteinase inhibitors, and the methods for making these
EP0639689A3 (en) Multi-stage borehole cementing device.
PL371122A1 (en) Process for preparing 3,3',5,5',6,6'-hexaalkyl-2,2'-biphenols, 3,3',4,4',5,5'-hexaalkyl-2,2'-biphenols and 3,3',4,4',5,5',6,6'-octaalkyl-2,2'-biphenols
AU7227394A (en) Method for surface treatment, means for carrying out the method and the use thereof
AU2001287890A1 (en) Radiotherapy apparatus and collimator set therefor
HU9802132D0 (en) Biphenyl-sulfonyl-cyanamides, process for producing them and their medical use
MX198647B (es) La preparacion de oligoaminas y poliaminas.
FI960658A7 (fi) Uudet bis-naftalimidit syövän hoitamiseksi
WO2004082631A3 (en) METHODS FOR PREPARATION AND USE OF 1α,24(S)-DIHYDROXYVITAMIN D2
AP2004003070A0 (en) The method of treating cancer.
FI953534A0 (fi) Menetelmä sellaisten yksölöiden tunnistamiseksi ja hoitamiseksi, joilla on HLA-C-klooni 10/MAGE-1:tä ekspressoivia syöpäsoluja
MXPA04010915A (es) Base y procedimiento de conocimiento de recursos humanos dinamicos.
AU7641898A (en) Ion paris, method for the production and use thereof as contrast agents
TR200102576T2 (tr) Kanser tedavisinde radyoaktif sisplatin
ZA971217B (en) Diamond treatment.
Font et al. Finding the words: Instruments for a therapy of liberation
AU3037000A (en) Agents for treating textiles, method for producing them and their use
BR0008791A (pt) Derivados anticonvulsivos, úteis no tratamento de tremor essencial

Legal Events

Date Code Title Description
FA Abandonment or withdrawal